Indiana Hemophilia & Thrombosis Center Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2001
NCT00157105
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Indiana Hemophilia &Thrombosis Center, Inc.